These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 17699108

  • 1. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R.
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [Abstract] [Full Text] [Related]

  • 2. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 3. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 4. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.
    Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571
    [Abstract] [Full Text] [Related]

  • 5. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H.
    Oncogene; 2002 Mar 27; 21(13):2000-8. PubMed ID: 11960372
    [Abstract] [Full Text] [Related]

  • 6. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV.
    Clin Cancer Res; 2006 Sep 01; 12(17):5055-63. PubMed ID: 16951221
    [Abstract] [Full Text] [Related]

  • 7. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH, Manoharan HT, Church DR, Dreckschmidt NE, Zhong W, Oberley TD, Wilding G, Verma AK.
    Cancer Res; 2007 Sep 15; 67(18):8828-38. PubMed ID: 17875724
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS, Nagle RB, Bowden GT.
    Prostate; 2004 Jan 01; 58(1):66-75. PubMed ID: 14673954
    [Abstract] [Full Text] [Related]

  • 9. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L, Chiang KY, Zhu N, Findley HW, Zhou M.
    Exp Hematol; 2007 Jun 01; 35(6):957-66. PubMed ID: 17533050
    [Abstract] [Full Text] [Related]

  • 10. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A, Yu Y, Lu Z, Mao X, Ren Z, Watowich SS, Mills GB, Liao WS, Chen X, Bast RC, Luo RZ.
    Cancer Res; 2005 Aug 01; 65(15):6701-10. PubMed ID: 16061651
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
    Ni Z, Lou W, Leman ES, Gao AC.
    Cancer Res; 2000 Mar 01; 60(5):1225-8. PubMed ID: 10728680
    [Abstract] [Full Text] [Related]

  • 12. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R.
    Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264
    [Abstract] [Full Text] [Related]

  • 13. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
    Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA.
    Cancer Res; 2005 Jun 15; 65(12):5054-62. PubMed ID: 15958548
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
    Stearns ME, Kim G, Garcia F, Wang M.
    Mol Cancer Res; 2004 Jul 15; 2(7):403-16. PubMed ID: 15280448
    [Abstract] [Full Text] [Related]

  • 15. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
    Yu CY, Wang L, Khaletskiy A, Farrar WL, Larner A, Colburn NH, Li JJ.
    Oncogene; 2002 Jun 06; 21(25):3949-60. PubMed ID: 12037677
    [Abstract] [Full Text] [Related]

  • 16. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
    Wojcik EJ, Sharifpoor S, Miller NA, Wright TG, Watering R, Tremblay EA, Swan K, Mueller CR, Elliott BE.
    Oncogene; 2006 May 04; 25(19):2773-84. PubMed ID: 16407846
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of potential Stat3-regulated genes in human breast cancer.
    Hsieh FC, Cheng G, Lin J.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):292-9. PubMed ID: 16081048
    [Abstract] [Full Text] [Related]

  • 18. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H, Minoda Y, Saeki K, Koga K, Takaesu G, Onodera M, Yoshimura A, Kobayashi T.
    Int Immunol; 2007 May 23; 19(5):609-19. PubMed ID: 17383969
    [Abstract] [Full Text] [Related]

  • 19. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.
    Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO, Lou W, Johnson CS, Trump DL, Gao AC.
    Prostate; 2004 Aug 01; 60(3):178-86. PubMed ID: 15176047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.